Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early Detection, and Physical Therapy Intervention
Taiwan: Institutional Review Board
1 other identifier
interventional
60
1 country
1
Brief Summary
Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early detection, and Physical Therapy Intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 28, 2013
CompletedFirst Posted
Study publicly available on registry
December 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedDecember 9, 2013
December 1, 2013
1 year
November 28, 2013
December 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to trismus Progression
up to 2 years
Study Arms (4)
Mastictors sparing group
ACTIVE COMPARATORUsing IMRT or HT to do masticators sparing techniques and physical therapy to prevent trismus.
Masticators not sparing group
NO INTERVENTIONThe patients do not receive masticators sparing technique as traditional techniques but still receive physical therapy after radiotherapy to prevent trismus.
EA group
ACTIVE COMPARATORUsing masticators sparing techniques and electro-acupunture stimulation to prevent trismus
Sham-EA group
SHAM COMPARATORUsing masticators sparing techniques but with sham EA stimulation.
Interventions
Eligibility Criteria
You may qualify if:
- Head and neck cancer underwent surgery followed by postoperative IMRT or HT with or without chemotherapy
You may not qualify if:
- Patients treated for recurrent squamous cell carcinomas of the oral cavity (including neck recurrences) are excluded from this analysis. -distance metastasis, previous received radiotherapy or concurrent chemoradation therapy are excluded from this analysis. Patients treated for recurrent squamous cell carcinomas of the oral cavity (including neck recurrences) are excluded from this analysis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Far Eastern Memorial Hospital
New Taipei City, 220, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2013
First Posted
December 9, 2013
Study Start
March 1, 2013
Primary Completion
March 1, 2014
Last Updated
December 9, 2013
Record last verified: 2013-12